Efficacy of Ceftazidime-avibactam Plus Aztreonam in Patients With Bloodstream Infections Caused by Metallo-β-lactamase–Producing Enterobacterales | Synapse

⌘+K

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Risk factors and epidemiologic predictors of blood stream infections with New Delhi Metallo-b-lactamase (NDM-1) producing<i>Enterobacteriaceae</i>Retrospective Study · 2019 · 49 citations
2The Balkan region: NDM-1-producing Klebsiella pneumoniae ST11 clonal strain causing outbreaks in GreeceOriginal Research · 2014 · 114 citations
3Epidemiology and resistance phenotypes of carbapenemase-producing Klebsiella pneumoniae in Greece, 2014 to 2016Original Research · 2018 · 90 citations
4Clinical Features and Outcomes of Bloodstream Infections Caused by New Delhi Metallo-β-Lactamase–Producing Enterobacterales During a Regional OutbreakOriginal Research · 2020 · 75 citations
5NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care SettingsOriginal Research · 2019 · 718 citations
6Can Ceftazidime-Avibactam and Aztreonam Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae?Original Research · 2017 · 295 citations
7Spotlight on ceftazidime/avibactam: a new option for MDR Gram-negative infectionsLate-Phase Clinical Trial · 2016 · 180 citations
8The first NDM metallo-β-lactamase producing <i>Klebsiella pneumoniae</i> isolate in a University Hospital of Southwestern GreeceOriginal Research · 2015 · 11 citations
9Outpatient Antibiotic Fills and 30-Day Readmission Following Patient-Directed Discharge in Drug Use-Associated Infective Endocarditis in a National Medicaid CohortClinical Infectious Diseases · 2026
10Randomized Trial Comparing Minocycline-EDTA-Ethanol Lock to Standard-of-Care Antibiotic Lock for Management of Central Line–Associated Bloodstream InfectionClinical Infectious Diseases · 2026

More from Clinical Infectious Diseases

More from University of Pisa